PIERIS PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Pieris Pharmaceuticals, Inc. - PIRS
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 20 2024
0mins
Should l Buy ?
Source: Businesswire
Investigation of Merger: Former Louisiana Attorney General Charles C. Foti, Jr. and Kahn Swick & Foti, LLC are investigating the proposed merger between Pieris Pharmaceuticals, Inc. and Palvella Therapeutics, Inc., focusing on the fairness of the transaction for Pieris shareholders.
Contact Information: Interested parties can discuss their legal rights regarding the merger with KSF at no cost, through email or phone, and further information is available on their website.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
